BULL HORN HOLDINGS CORP.

Company

Coeptis Therapeutics Holdings, Inc.

Filed

February 4, 2021

Accession Number

0000902664-21-000843

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →